Zyban

   
Google
 
Web NewDrugInformation.com

Zyban


Drug - Zyban
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bupropion Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 100MG
The potency of the active ingredient(s), Bupropion Hydrochloride. May repeat for multiple part products.

Applicant - GLAXOSMITHKLINE
The firm name holding legal responsibility for Zyban. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020711
The FDA assigned number to Zyban. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Zyban. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 14, 1997
The date Zyban was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Zyban. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Zyban is in. Format is RX, OTC, DISCN.

Applicant Full Name - Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Zyban.

Zyban